Extracorporeal Membrane Oxygenation for the Management of Respiratory Failure Caused by Diffuse Alveolar Hemorrhage
Zhen Guo, Xin Li, Liyan Jiang, Lingfeng Xu
Abstract
Open-access reader
Zhen Guo, Xin Li, Liyan Jiang, Lingfeng Xu
Abstract
Open-access reader
Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy to treat severe respiratory failure. When conventional mechanical ventilation has failed or when there is not enough time to treat the pathology, ECMO has the potential to sustain life. In this report, successful use of ECMO to support an adult patient with antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides complicated by severe respiratory failure caused by diffuse alveolar hemorrhage will be discussed.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Extracorporeal membrane oxygenation (ECMO) was developed as a supportive therapy to treat severe respiratory failure. When conventional mechanical ventilation has failed or when there is not enough time to treat the pathology, ECMO has the potential to sustain life. In this report, successful use of ECMO to support an adult patient with antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides complicated by severe respiratory failure caused by diffuse alveolar hemorrhage will be discussed.
Key concepts: Diffuse alveolar hemorrhage, Medicine, Extracorporeal membrane oxygenation, Respiratory failure, Mechanical ventilation, Extracorporeal, Acute respiratory failure, Respiratory system